GMDA
Price:
$0.0327
Market Cap:
$4.34M
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin ...[Read more]
Industry
Biotechnology
IPO Date
2018-10-26
Stock Exchange
NASDAQ
Ticker
GMDA
According to Gamida Cell Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -99.34% compared to the average of -6.06 of the last 4 quarters.
The mean historical PE Ratio of Gamida Cell Ltd. over the last ten years is -3.87. The current -0.04 PE Ratio has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), GMDA's PE Ratio was at its highest in in the June 2019 quarter at 5.53. The PE Ratio was at its lowest in in the September 2023 quarter at -21.06.
Average
-3.87
Median
-4.19
Minimum
-7.98
Maximum
-0.53
Discovering the peaks and valleys of Gamida Cell Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.49%
Maximum Annual PE Ratio = -0.53
Minimum Annual Increase = -67.24%
Minimum Annual PE Ratio = -7.98
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.97 | 82.49% |
| 2022 | -0.53 | -67.24% |
| 2021 | -1.63 | -66.07% |
| 2020 | -4.80 | 30.13% |
| 2019 | -3.69 | -21.36% |
| 2018 | -4.69 | -41.23% |
| 2017 | -7.98 | 19.25% |
The current PE Ratio of Gamida Cell Ltd. (GMDA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.05
5-year avg
-2.32
10-year avg
-3.87
Gamida Cell Ltd.’s PE Ratio is greater than Aptose Biosciences Inc. (-0.16), less than Gritstone bio, Inc. (-0.03), less than Nabriva Therapeutics plc (-0.00), greater than TNF Pharmaceuticals, Inc. (-0.19), less than Atreca, Inc. (-0.04), greater than Neuphoria Therapeutics Inc. (-0.39), greater than Hillstream BioPharma, Inc. (-0.66), less than Altamira Therapeutics Ltd. (-0.02), greater than Idera Pharmaceuticals, Inc. (-0.06), greater than RVL Pharmaceuticals plc (-0.05),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.16 | $4.36M | |
| -0.03 | $3.80M | |
| -0.00 | $323.00 | |
| -0.19 | $9.18M | |
| -0.04 | $3.57M | |
| -0.39 | $23.29M | |
| -0.66 | $4.17M | |
| -0.02 | $1.13M | |
| -0.06 | $0 | |
| -0.05 | $3.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gamida Cell Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gamida Cell Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Gamida Cell Ltd.'s PE Ratio?
How is the PE Ratio calculated for Gamida Cell Ltd. (GMDA)?
What is the highest PE Ratio for Gamida Cell Ltd. (GMDA)?
What is the 3-year average PE Ratio for Gamida Cell Ltd. (GMDA)?
What is the 5-year average PE Ratio for Gamida Cell Ltd. (GMDA)?
How does the current PE Ratio for Gamida Cell Ltd. (GMDA) compare to its historical average?